FeesSafety
Pluang+

Nyxoah to release Q3 2026 financial results on Nov 5 with a conference call scheduled.

Company Fundamentals
27 Oct 2026, 00:05 WIB
GlobeNewsWire
View Source
Neutral
Nyxoah to release Q3 2026 financial results on Nov 5 with a conference call scheduled.

Nyxoah, a medical technology company specializing in treatments for Obstructive Sleep Apnea (OSA), announced it will release its third quarter 2026 financial results on November 5, 2026. The company will hold a conference call to discuss the results, accessible via webcast or phone for investors. Nyxoah's lead product, the Genio system, offers a novel neurostimulation therapy for OSA and has received regulatory approvals in Europe and the U.S. This earnings release will provide insights into the company's financial health and progress in commercializing its innovative treatment.

Nyxoah's upcoming Q3 2026 financial results are noted here with Pluang's health sector market data as context. As of Oct 27, 2026 03:11 WIB, out of 150 health-sector US stocks on Pluang, 80 rose and 70 fell. GeneDx Holdings Corp (WGS) rose 6.98% to USD 60.07 with a typical hold time of 20 days and 58% buy orders, contrasting with Summit Therapeutics Inc (SMMT) which fell 6.37% to USD 14.48 and had an even split of buy and sell orders. Inovio Pharmaceuticals Inc (INO) gained 6.44% to USD 0.89, held typically for 43 days, with 87% buy orders.

More News

Presidio named Global Innovation Partner of the Year at Cisco Partner Summit 2026

Presidio named Global Innovation Partner of the Year at Cisco Partner Summit 2026

At the Cisco Partner Summit 2026, Presidio was honored as the Global Innovation Partner of the Year, recognizing its outstanding innovation and success in delivering impactful customer solutions. This award highlights Presidio's commitment to partner...

Market News
Bullish
1 hour ago
Presidio named Global Services and Software Excellence Partner of the Year at Cisco Partner Summit 2026

Presidio named Global Services and Software Excellence Partner of the Year at Cisco Partner Summit 2026

Presidio was awarded the Global Services and Software Excellence Partner of the Year at the Cisco Partner Summit 2026. This award recognizes Presidio's outstanding innovation and success in delivering solutions that help customers achieve meaningful ...

Market News
Bullish
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
3 hours ago
Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
3 hours ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App